Editorial: Glucocorticoids for Graves' ophthalmopathy: How and when

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 9, 2005, Pages 5497-5499

  Bartalena, Luigi ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; PREDNISONE; RADIOACTIVE IODINE;

CLINICAL TRIAL; CUSHING SYNDROME; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG INDICATION; DRUG MONITORING; DRUG WITHDRAWAL; EDITORIAL; ENDOCRINE OPHTHALMOPATHY; ENDOCRINE SURGERY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIVER INJURY; PRIORITY JOURNAL;

GLUCOCORTICOIDS; GRAVES DISEASE; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 24344476250     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-1553     Document Type: Editorial

References (21)

1. Ludgate M, Baker G 2004 Inducing Graves' ophthalmopathy. J Endocrinol Invest 27:211-215
2. Bahn RS 2004 TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy. J Endocrinol Invest 27:216-220
3. Ajjan RA, Weetman AP 2004 New understanding of the role of cytokines in the pathogenesis of Graves' ophthalmopathy. J Endocrinol Invest 27:237-245
4. Bartalena L, Pinchera A, Marcocci C 2000 Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 21:168-199
5. Wiersinga WM, Prummel MF, Terwee CB 2004 Effects of Graves' ophthalmopathy on quality of life. J Endocrinol Invest 27:259-264
6. Marcocci C, Marinò M, Rocchi R, Menconi F, Morabito E, Pinchera A 2004 Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy. J Endocrinol Invest 27:272-280
7. Bartalena L, Marcocci C, Gorman CA, Wiersinga WM, Pinchera A 2003 Orbital radiotherapy for Graves' ophthalmopathy: Useful or useless? Safe or dangerous? J Endocrinol Invest 26:5-16
8. Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB 2001 A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy. Ophthalmology 108:1523-1534
9. Bartalena L, Marcocci C, Pinchera A 2004 Orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 89:13-14
10. Marcocci C, Bartalena L, Rocchi R, Marinò M, Monconi F, Morabito E, Mazzi B, Mazzeo S, Sartini MS, Nardi M, Cartei F, Cionini L, Pinchera A 2003 Long-term safety of orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 88:3561-3566
11. Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A 2001 Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab 86:3562-3567
12. Marinò M, Morabito E, Brunetto MR, Bartalena L, Pinchera A, Marcocci C 2004 Acute and severe liver damage associated with intravenous glucocorticoid pulse therapy in patients with Graves' ophthalmopathy. Thyroid 14:403-406
13. Kahaly GJ, Pitz S, Hommel G, Dittmar M 2005 Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy. J Clin Endocrinol Metab 90:5234-5240
14. Bartalena L, Tanda ML, Piantanida E, Lai A, Pinchera A 2004 Relationship between management of hyperthyroidism and course of the ophthalmopathy. J Endocrinol Invest 27:288-294
15. Hegedus L, Brix TH, Vestergaard P 2004 Relationship between cigarette smoking and Graves' ophthalmopathy. J Endocrinol Invest 27:265-271
16. Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren J-G, Blomgren H, Taube A, and the Thyroid Study Group 1992 Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. N Engl J Med 326:1733-1738.
17. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A 1998 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338:73-78
18. Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A 1989 Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 321:1349-1352
19. Bartalena L, Tanda ML, Piantanida E, Lai A 2005 Glucocorticoids and outcome of radioactive iodine therapy for Graves' hyperthyroidism. Eur J Endocrinol 153:13-14
20. Perros P, Kendall-Taylor P, Neoh C, Frewin S, Dickinson J 2005Aprospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopathy. J Clin Endocrinol Metab 90:5321-5323
21. Wiersinga WM 1998 Preventing Graves' ophthalmopathy. N Engl J Med 338:121-122